Joshua M. Bradner
Emory University(US)AbbVie (United States)(US)Columbia University(US)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Neuroscience and Neuropharmacology Research, Cellular transport and secretion, Alzheimer's disease research and treatments, Toxic Organic Pollutants Impact
Most-Cited Works
- → DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease(2010)605 cited
- → Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression(2010)414 cited
- → Rab11a and HSP90 Regulate Recycling of Extracellular α-Synuclein(2009)132 cited
- → Complement 3 and Factor H in Human Cerebrospinal Fluid in Parkinson's Disease, Alzheimer's Disease, and Multiple-System Atrophy(2011)121 cited
- → Identification of Glutathione S-Transferase Pi as a Protein Involved in Parkinson Disease Progression(2009)84 cited
- → Exposure to the polybrominated diphenyl ether mixture DE-71 damages the nigrostriatal dopamine system: Role of dopamine handling in neurotoxicity(2012)62 cited